180 related articles for article (PubMed ID: 2562001)
21. Opioid peptides. Structure-activity relationships in [OGly4] dermorphin tetrapeptides. X.
Salvadori S; Minozzi L; Tomatis R
Farmaco Sci; 1986 Feb; 41(2):103-10. PubMed ID: 3699145
[TBL] [Abstract][Full Text] [Related]
22. Opioid peptides. Synthesis and binding assays of desamino-Tyr1 dermorphin analogues. XII.
Salvadori S; Marastoni M; Balboni G; Tomatis R; Borea PA
Farmaco Sci; 1987 Dec; 42(12):931-40. PubMed ID: 2896601
[TBL] [Abstract][Full Text] [Related]
23. Acetalins: opioid receptor antagonists determined through the use of synthetic peptide combinatorial libraries.
Dooley CT; Chung NN; Schiller PW; Houghten RA
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10811-5. PubMed ID: 8248174
[TBL] [Abstract][Full Text] [Related]
24. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
Shenderovich MD; Nikiforovich GV; Golbraikh AA
Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-D-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffold.
Ballet S; Frycia A; Piron J; Chung NN; Schiller PW; Kosson P; Lipkowski AW; Tourwé D
J Pept Res; 2005 Nov; 66(5):222-30. PubMed ID: 16218989
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position.
Schiller PW; Nguyen TM; Maziak LA; Wilkes BC; Lemieux C
J Med Chem; 1987 Nov; 30(11):2094-9. PubMed ID: 2822930
[TBL] [Abstract][Full Text] [Related]
27. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
28. Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.
Sakurada S; Chaki K; Watanabe H; Nakata N; Sakurada T; Kisara K; Suzuki K
J Pharmacol Exp Ther; 1992 Nov; 263(2):793-9. PubMed ID: 1331414
[TBL] [Abstract][Full Text] [Related]
29. Minimum structure opioids-dipeptide and tripeptide analogs of the enkephalins.
Vavrek RJ; Hsi LH; York EJ; Hall ME; Stewart JM
Peptides; 1981; 2(3):303-8. PubMed ID: 6272246
[TBL] [Abstract][Full Text] [Related]
30. New features of the delta opioid receptor: conformational properties of deltorphin I analogues.
Balboni G; Marastoni M; Picone D; Salvadori S; Tancredi T; Temussi PA; Tomatis R
Biochem Biophys Res Commun; 1990 Jun; 169(2):617-22. PubMed ID: 2162669
[TBL] [Abstract][Full Text] [Related]
31. Opioid peptides. Structure-activity relationships in [beta-Ala4]dermorphin tetrapeptides. V.
Salvadori S; Marastoni M; Tomatis R; Sarto G
Farmaco Sci; 1983 Sep; 38(9):640-6. PubMed ID: 6641929
[TBL] [Abstract][Full Text] [Related]
32. Dermorphin interaction with rat brain opioid receptors: involvement of hydrophobic sites in the binding domain.
Lazarus LH; Wilson WE; Guglietta A; de Castiglione R
Mol Pharmacol; 1990 Jun; 37(6):886-92. PubMed ID: 2163014
[TBL] [Abstract][Full Text] [Related]
33. Structural requirements for dermorphin opioid receptor binding.
Amiche M; Delfour A; Nicolas P
Int J Pept Protein Res; 1988 Jul; 32(1):28-34. PubMed ID: 2906053
[TBL] [Abstract][Full Text] [Related]
34. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
Olianas MC; Onali P
Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
[TBL] [Abstract][Full Text] [Related]
35. Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity.
Labroo VM; Hebel D; Kirk KL; Cohen LA; Lemieux C; Schiller PW
Int J Pept Protein Res; 1991 May; 37(5):430-9. PubMed ID: 1680830
[TBL] [Abstract][Full Text] [Related]
36. Identification of a D-alanine-containing polypeptide precursor for the peptide opioid, dermorphin.
Mor A; Delfour A; Nicolas P
J Biol Chem; 1991 Apr; 266(10):6264-70. PubMed ID: 2007579
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of new opiate-like peptides using a radioreceptor method].
Shestak KI; Sergeeva MG; Zaĭtsev SV; Kharchenko EP; Varfolomeev SD; Kalikhevich VN; Ardemasova ZA
Ukr Biokhim Zh (1978); 1990; 62(2):23-9. PubMed ID: 1973313
[TBL] [Abstract][Full Text] [Related]
38. [Dermorphin: synthesis of analogs and structuro-functional relations].
Korshunova GA; Sumbatian NV
Bioorg Khim; 1989 Jul; 15(7):869-903. PubMed ID: 2684167
[TBL] [Abstract][Full Text] [Related]
39. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
Mosberg HI; Heyl DL; Haaseth RC; Omnaas JR; Medzihradsky F; Smith CB
Mol Pharmacol; 1990 Dec; 38(6):924-8. PubMed ID: 2174509
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of dermorphins, a new class of opiate-like peptides.
de Castiglione R; Faoro F; Perseo G; Piani S
Int J Pept Protein Res; 1981 Feb; 17(2):263-72. PubMed ID: 7228501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
